BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20698041)

  • 21. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer.
    Koike T; Nakagawa K; Iijima K; Shimosegawa T
    Dig Endosc; 2013 Mar; 25 Suppl 1():20-8. PubMed ID: 23480400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
    Rusch VW; Levine DS; Haggitt R; Reid BJ
    Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management controversies in Barrett's oesophagus.
    Max Almond L; Barr H
    J Gastroenterol; 2014 Feb; 49(2):195-205. PubMed ID: 23736794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 28. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 32. Endoscopic therapy of neoplasia related to Barrett's esophagus and endoscopic palliation of esophageal cancer.
    Vignesh S; Hoffe SE; Meredith KL; Shridhar R; Almhanna K; Gupta AK
    Cancer Control; 2013 Apr; 20(2):117-29. PubMed ID: 23571702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer.
    Seewald S; Ang TL; Soehendra N
    Postgrad Med J; 2007 Jun; 83(980):367-72. PubMed ID: 17551066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive esophagectomy for dysplastic Barrett's esophagus.
    Markar SR; Hanna G
    World J Surg; 2015 Mar; 39(3):608-14. PubMed ID: 25145822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind.
    Peters JH
    J Gastrointest Surg; 2009 Jul; 13(7):1179-81. PubMed ID: 19294473
    [No Abstract]   [Full Text] [Related]  

  • 37. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma.
    Hunt BM; Louie BE; Dunst CM; Lipham JC; Farivar AS; Sharata A; Aye RW
    Dis Esophagus; 2014; 27(4):362-7. PubMed ID: 23795720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal preservation in esophageal high-grade dysplasia and intramucosal adenocarcinoma.
    Hoppo T; Rachit SD; Jobe BA
    Thorac Surg Clin; 2011 Nov; 21(4):527-40. PubMed ID: 22040635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O; Ell C
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma.
    Scotiniotis IA; Kochman ML; Lewis JD; Furth EE; Rosato EF; Ginsberg GG
    Gastrointest Endosc; 2001 Dec; 54(6):689-96. PubMed ID: 11726843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.